The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: Primary analysis of the ctDNA-positive cohort from the randomized AGITG dynamic-III trial (intergroup study of AGITG and CCTG).
 
Jeanne Tie
Honoraria - Merck Serono; MSD Oncology
Consulting or Advisory Role - Arcus Biosciences (Inst); BeiGene; Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Haystack Oncology; Illumina; MSD Oncology; Pierre Fabre; Roche; Takeda
Speakers' Bureau - MSD Oncology
Research Funding - Grail (Inst); Haystack Oncology (Inst); Pierre Fabre (Inst)
 
Yuxuan Wang
Consulting or Advisory Role - Belay Diagnostics; Exact Sciences/Thrive Earlier Detection
Patents, Royalties, Other Intellectual Property - U.S. Patent UA2015/0292027: Papanicolaou Test for Ovarian and Endometrial Cancers.; U.S. Patent US2018/0171413: Detection of Tumor-Derived DNA in Cerebrospinal Fluid.; U.S. Patent US2018/0171413: Detection of Tumor-Specific DNA in Saliva and Blood.; U.S. Patent US2018/0258490: Diagnostic Potential of Tumor DNA from Ovarian Cyst Fluid.; U.S. Patent US2018/045669: Methods and Materials for Assessing and Treating Cancer.; U.S. Patent US2018/045669: Methods and Materials for Assessing and Treating Cancer.
 
Jonathan Loree
Consulting or Advisory Role - Advanced Accelerator Applications; AMGEN; Bayer; Guardant Health; Ipsen; Merck; Roche; Taiho Pharmaceutical
Research Funding - Ipsen (Inst); Personalis
 
Joshua Cohen
No Relationships to Disclose
 
David Espinosa
No Relationships to Disclose
 
Rachel Wong
Consulting or Advisory Role - Bristol Meyers Squibb; MSD; MSD; MSD
Travel, Accommodations, Expenses - AstraZeneca; MSD
 
Timothy Price
Honoraria - Amgen; Takeda
Consulting or Advisory Role - Amgen; MSD Oncology; SERVIER; Takeda
Research Funding - AMGEN (Inst)
(OPTIONAL) Uncompensated Relationships - Duo Oncology
 
Niall Tebbutt
Honoraria - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck; Takeda
Expert Testimony - Astellas Pharma
 
Margaret Lee
No Relationships to Disclose
 
Matthew Burge
Stock and Other Ownership Interests - coclear; CSL Limited; Lilly; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
Samuel Harris
No Relationships to Disclose
 
Belinda Lee
Honoraria - Roche
Research Funding - AngioDynamics (Inst); Servier (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche
 
James Lynam
Employment - Precision for Medicine
Leadership - Healthscope Advanced Pathology; Healthscope Advanced Pathology
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
(OPTIONAL) Uncompensated Relationships - Medical Oncology Group of Australia
 
Christopher O'Callaghan
No Relationships to Disclose
 
Daniel Breadner
Stock and Other Ownership Interests - Need
Consulting or Advisory Role - Amgen; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Guardant Health; Janssen Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca Canada; Bayer; Merck; Roche Canada
Research Funding - Pfizer (Inst)
 
Chetan Bettegowda
No Relationships to Disclose
 
Nickolas Papadopoulos
Leadership - Exact Sciences
Stock and Other Ownership Interests - Cage Pharma; Exact Sciences; Haystack Oncology; ManaT Bio
Consulting or Advisory Role - Exact Sciences; NeoPhore
Patents, Royalties, Other Intellectual Property - Cage Pharma (Inst); Exact Sciences (Inst); Haystack Oncology (Inst); ManaT Bio (Inst)
 
Kenneth Kinzler
Leadership - Haystack Oncology; Thrive Earlier Detection Corp
Stock and Other Ownership Interests - Cage Pharma; Exact Sciences/Thrive Earlier Detection; Haystack Oncology; ManaT Bio; NeoPhore
Consulting or Advisory Role - Cage Pharma; Exact Sciences/Thrive Earlier Detection; Haystack Oncology; ManaT Bio; NeoPhore
Patents, Royalties, Other Intellectual Property - Cage Pharma (Inst); Exact Sciences/Thrive Earlier Detection (Inst); Haystack Oncology (Inst); ManaT Bio (Inst); NeoPhore (Inst)
 
Bert Vogelstein
Consulting or Advisory Role - Cage Pharma; Catalio Capital Management; Haystack Oncology; Thrive Earlier Detection Corp
Patents, Royalties, Other Intellectual Property - The companies named above, as well as other companies, have licensed previously described technologies related to the work described in this paper from Johns Hopkins University. B.V. is an inventor on some of these technologies. Licenses to these technolo
 
Peter Gibbs
Honoraria - Bristol-Myers Squibb/Sanofi; Merck; MSD Oncology; Pierre Fabre; SERVIER
Consulting or Advisory Role - Haystack Oncology
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb/Sanofi (Inst); GRAIL (Inst); Haystack Oncology (Inst); Merck Serono (Inst); Pierre Fabre (Inst); Roche (Inst); Servier (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Servier